3 research outputs found

    DataSheet1_Multi-omics analysis reveals the pathogenesis of db/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza.docx

    No full text
    Diabetic kidney disease (DKD) is a common diabetic complication. Salvia miltiorrhiza has significant therapeutic effects on diabetes complications, although the mechanism remains unclear. Here, biochemical indicators and pathological changes were used to screen out the optimal Salvia miltiorrhiza multi-bioactive compounds combination. Metabolomics, transcriptomics and proteomics were used to explore the pathogenesis of DKD. RT-PCR and parallel reaction monitoring targeted quantitative proteome analysis were utilized to investigate treatment mechanisms of the optimal Salvia miltiorrhiza multi-bioactive compounds combination. The db/db mice showed biochemical abnormalities and renal lesions. The possible metabolic pathways were steroid hormone biosynthesis and sphingolipid metabolism. The 727 differential genes found in transcriptomics were associated with biochemical indicators via gene network to finally screen 11 differential genes, which were mainly key genes of TGF-β/Smad and PI3K/Akt/FoxO signaling pathways. Salvia miltiorrhiza multi-bioactive compounds combination could significantly regulate the Egr1, Pik3r3 and Col1a1 genes. 11 differentially expressed proteins involved in the two pathways were selected, of which 9 were significantly altered in db/db mice compared to db/m mice. Salvia miltiorrhiza multi-bioactive compounds combination could callback Q9DBM2, S4R1W1, Q91Y97, P47738, A8DUK4, and A2ARV4. In summary, Salvia miltiorrhiza multi-bioactive compounds combination may ameliorate kidney injury in diabetes through regulation of TGF-β/Smad and PI3K/Akt/FoxO signaling pathways.</p

    Highly Efficient Ruddlesden–Popper Halide Perovskite PA<sub>2</sub>MA<sub>4</sub>Pb<sub>5</sub>I<sub>16</sub> Solar Cells

    No full text
    Two-dimensional (2D) Ruddlesden–Popper (RP) organic–inorganic perovskites have emerged as promising candidates for solar cells with technologically relevant stability. Herein, a new RP perovskite, the fifth member (⟨<i>n</i>⟩ = 5) of the (CH<sub>3</sub>(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>)<sub>2</sub>(CH<sub>3</sub>NH<sub>3</sub>)<sub><i>n</i>−1</sub>Pb<sub><i>n</i></sub>I<sub>3<i>n</i>+1</sub> family (abbreviated as PA<sub>2</sub>MA<sub>4</sub>Pb<sub>5</sub>I<sub>16</sub>), was synthesized and systematically investigated in terms of photovoltaic application. The obtained pure PA<sub>2</sub>MA<sub>4</sub>Pb<sub>5</sub>I<sub>16</sub> crystal exhibits a direct band gap of <i>E</i><sub>g</sub> = 1.85 eV. Systematic analysis on the solid film highlights the key role of the precursor–solvent interaction in the quantum well orientation, phase purity, grain size, surface quality, and optoelectronic properties, which can be well-tuned with addition of dimethyl sulfoxide (DMSO) into the <i>N</i>,<i>N</i>-dimethylformamide (DMF) precursor solution. These findings present opportunities for designing a high-quality RP film with well-controlled quantum well orientation, micrometer-sized grains, and optoelectronic properties. As a result, we achieved power conversion efficiency (PCE) up to 10.41%
    corecore